Find a Tender
complete
Official procurement procedure
Supply of Favipiravir Tablets (Avigan)
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health and Social Care: "Supply of Favipiravir Tablets (Avigan)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Department of Health and Social Care | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Department of Health and Social Care
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Department of Health and Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
11.8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 451 active published awards; 397 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDepartment of Health and Social Care | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published5 Mar 2021, 13:40 GMT | Last source update5 Mar 2021, 13:40 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0298c4 | ||
What is being bought
The Department of Health and Social Care (DHSC) has awarded a contract for the supply, repackaging and relabelling of Favipiravir (Avigan) for Covid-19.
What changed
From the official release history
- Status changed to complete
5 Mar 2021, 13:40 GMT - Official notice release published
5 Mar 2021, 13:40 GMT - Buyer information updated
5 Mar 2021, 13:40 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe Department of Health and Social Care conducted a negotiated procedure without prior publication under the Public Contracts Regulations 2015 (as amended) for the supply of 300 packs of 100 tablets of Favipiravir 200mg (Avigan). The contract period expires on 31 March 2021.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
5 Mar 2021, 13:40 GMT - Award active
Not published · Not published - Contract active
Signed 3 Feb 2021, 00:00 GMT · £1
Commercial outcome and competition
Awards IPS Pharma t/a Vertical Pharma Resources Limited Not published · Not published · active |
Contracts Contract £1 · signed 3 Feb 2021, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
Department of Health and Social Care
Contracting authority GB-FTS-43Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe Coronavirus disease (COVID-19) gave rise to an extremely urgent need for the Authority to purchase a quantity of Favipiravir because the Authority needs to be in a position to treat the population as required such that did not give the Authority sufficient time to comply with the standard Open Procedure time scales for this procurement. Accordingly, the Authority used the negotiated procedure without prior publication – Regulation 32(2)(c) – Extreme Urgency Route (i.e. direct award) permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement. |